Zydus Cadila launches COVID-19 drug Remdesivir in India


PTI, Aug 13, 2020, 10:38 AM IST

New Delhi: Drug firm Zydus Cadila on Thursday, August 13 said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market.

Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory filing.

The company said the drug will be made available across India through the group”s strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.

“Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of COVID-19,” Cadila Healthcare Managing Director Dr. Sharvil Patel said.

“Through the course of this pandemic, the company’s efforts have been focused on supporting people in this healthcare crisis, whether it is through developing vaccines, ramping up production and distribution of critical drugs and therapies, making diagnostic tests available, or exploring new treatment options,” Patel added.

In June this year, Zydus had entered into a non-exclusive agreement with Gilead Sciences Inc to manufacture and sell Remdesivir, the investigational drug, which has been issued an emergency use authorization by the US Food and Drug Administration (USFDA) to treat patients suffering from severe symptoms of COVID-19.

The active pharmaceutical ingredient (API) for the drug has been developed and manufactured at the group”s API manufacturing facilities in Gujarat.

Zydus Cadila”s vaccine candidate ZyCov-D is now in phase II of the clinical trials.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Mild tremors felt again in Dakshina Kannada

Alt News parent company Pravda Media received Rs 2 lakh from foreign countries: Police

Congress in K’taka releases booklet highlighting failures of BJP govt at Centre in 8 years

Agnipath scheme: Congress workers hold protest in Mangaluru

Contextual meeting with Amit Shah and Nadda: CM Bommai

Udaipur killing: Cong alleges one of main accused ‘BJP member’

Retired Karnataka SP gets 4 years in jail in disproportionate assets case


Related Articles More

Reliance Industries stock tumbles over 7 pc; ONGC tanks more than 13 pc

RBI ask banks to test note sorting machines on quarterly basis

India’s manufacturing sector activity eases to 9-month low in Jun amid price pressure

Bajaj Auto sales at 3,47,004 units in June

Govt hikes gold import duty to 15 pc

MUST WATCH

India’s first unmanned combat aircraft flight successful

How to earn God’s grace?

NEW BULLETIN 01-07-2022

Heavy Rain Mallar Urdu school Damage

Heavy rain at kaup area


Latest Additions

NIA to probe killing of chemist in Amravati in Maharashtra

Mild tremors felt again in Dakshina Kannada

Cong warns of legal action against BJP leaders for sharing ‘misleading’ Rahul video, demands apology

Alt News parent company Pravda Media received Rs 2 lakh from foreign countries: Police

MGNREGA played saviour for millions during COVID, but Modi did not acknowledge it: Rahul Gandhi

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.